SPRINT-TB Director Prof. Nicholas Paton and SPRINT-TB Manager Dr. Kristina Rutkute were interviewed by Clearstate, the Economist Intelligence Unit, to share their opinion for a white paper on the Singapore biosciences landscape 2025. The white paper was commissioned by BioSingapore, an industry association for life sciences businesses in Singapore.
The white paper has elicited views from a broad group of industry and research participants, influencers and key opinion leaders about the future of the biosciences industry in Singapore. It assesses trends impacting the biosciences sector, Singapore’s position vis-à-vis regional clusters, and analyses how Singapore should grow industry capabilities in the future. The publication provides themes that can help to guide the development of innovative ideas to propel the next lap of Biosciences growth in Singapore.
The white paper is available for download here.
SPRINT-TB Inaugural Annual Symposium: Advances in Tuberculosis Therapy Research was held at the National University of Singapore on September 18th, 2015.
This was the first in the series of symposiums that SPRINT-TB will host annually, each year featuring renowned local and international scientists, clinicians and key opinion leaders in TB. This year's programme included talks on mycobacterial targets, new TB drug candidates, clinical trials of novel TB treatment regimens, and public health. The symposium welcomed over 100 attendees.
Follow the symposium website www.tuberculosis.sg for announcements of the 2016 event.
View the event photo gallery: